tiprankstipranks
Trending News
More News >
Nutrien Ltd (TSE:NTR)
TSX:NTR

Nutrien (NTR) AI Stock Analysis

Compare
750 Followers

Top Page

TS

Nutrien

(TSX:NTR)

Rating:71Outperform
Price Target:
C$89.00
▲(10.56%Upside)
Nutrien's overall stock score reflects a stable financial performance amid challenges, with strengths in technical indicators and strategic actions. The strong balance sheet and cash flow generation provide a solid foundation, while the dividend yield offers some income potential. However, valuation concerns and market challenges weigh on the stock's potential upside.
Positive Factors
Agricultural Fundamentals
Agricultural fundamentals are generally stronger now, leading to improved stocks-to-use ratios and higher grain prices.
Corn Market Outlook
US corn planting is largely complete, and crop conditions are progressing well, indicating a strong 2025 crop outlook.
Potash Market Dynamics
New potash contracts with China and India are likely setting a new floor price, supporting some spot price momentum.
Negative Factors
Corn Price Decline
Recent decline in corn prices represents a mismatch with Nutrien's strong share performance, which is often unsustainable.
Downgrade and Upside Potential
The company is downgraded to Market Perform due to significant share price gains, which limits further upside potential.
Pricing Trends in Potash
Nutrien's large potash operation is likely to experience negative pricing comparisons because of adverse pricing trends.

Nutrien (NTR) vs. iShares MSCI Canada ETF (EWC)

Nutrien Business Overview & Revenue Model

Company DescriptionNutrien Ltd. is a leading global provider of crop inputs, services, and solutions. Operating in the agriculture sector, the company is primarily engaged in the production and distribution of potash, nitrogen, and phosphate products, which are essential nutrients for plant growth. Nutrien's core offerings include fertilizers, agriculture retail services, and various crop production products, serving farmers and agricultural producers worldwide.
How the Company Makes MoneyNutrien makes money through several key revenue streams. The primary sources include the sale of potash, nitrogen, and phosphate fertilizers, which are critical for enhancing crop yields and ensuring food security. Additionally, Nutrien operates a significant agriculture retail business, providing farmers with products and services such as seeds, crop protection products, and agronomic advice. The company's revenue is further supported by strategic partnerships and joint ventures in the agriculture industry, enhancing its market reach and operational efficiency. Nutrien's earnings are influenced by factors such as global agricultural demand, commodity prices, and seasonal planting patterns, which affect the sales volume and pricing of its products.

Nutrien Earnings Call Summary

Earnings Call Date:May 07, 2025
(Q1-2025)
|
% Change Since: 2.68%|
Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment Neutral
The earnings call highlights Nutrien's achievements in cost savings, strategic divestitures, and market strength in potash and retail sales. However, challenges such as weather-related delays, underperformance in the nitrogen and phosphate segments, and crop protection tariff impacts were noted. Overall, the sentiment is balanced with both significant achievements and challenges.
Q1-2025 Updates
Positive Updates
Positive Growth in U.S. Retail Fertilizer Sales
U.S. retail fertilizer sales volumes were up 8% in April compared to the same period in 2024, driven by strong fertilizer application rates and an anticipated 5% increase in corn acres in 2025.
Potash Market Strengthening
Global potash supply and demand fundamentals have strengthened significantly, with spot market prices increasing by 10% to 20% since the beginning of 2025. Canpotex is fully committed for the second quarter due to strong demand.
Cost-Saving Achievements
Nutrien is on track to achieve $200 million in consolidated annual cost savings by 2025, one year earlier than originally planned. Planned capital expenditures are down more than $500 million compared to 2023 levels.
Successful Divestiture of Non-Core Assets
Nutrien divested its remaining position in Sinofert, realizing total proceeds of $223 million. This supports the ability to deploy capital towards high-conviction priorities.
Encouraging Progress in Brazil
Nutrien is demonstrating greater stability in Brazil supported by margin improvement plans, focusing on cost savings, headcount reduction, and proprietary products.
Negative Updates
Weather-Related Delays in Retail Business
Weather-related delays reduced crop input sales in the U.S. and Australia, impacting the retail adjusted EBITDA, which totaled $46 million for the quarter.
Challenges in the Nitrogen Segment
The nitrogen segment's adjusted EBITDA was down due to higher natural gas costs and lower equity earnings from the investment in Profertil. Benchmark prices for ammonia have declined from historically strong levels in the fourth quarter of 2024.
Phosphate Segment Underperformance
Phosphate adjusted EBITDA was down primarily due to lower production volumes and higher input costs. Lower operating rates are expected in the first half of 2025.
Impact of Tariffs on Crop Protection
The crop protection segment faces challenges from generic competition and potential tariff impacts, although these are not expected to be material to 2025 earnings.
Company Guidance
In the 2025 First Quarter Earnings Call, Nutrien maintained its full-year guidance ranges despite the seasonal slowdown, citing strong global demand and tight supplies in the fertilizer market. U.S. retail fertilizer sales volumes increased by 8% in April, with U.S. farmers planning to boost corn acreage by approximately 5% in 2025. Global potash shipment forecasts were set between 71 and 75 million tonnes, with spot market prices rising 10% to 20% since early 2025. The company achieved adjusted EBITDA of $852 million in Q1, with retail adjusted EBITDA at $46 million. Annual guidance for retail adjusted EBITDA remained at $1.65 to $1.85 billion. Nutrien also reported progress in cost-saving initiatives, achieving $200 million in annual savings a year ahead of schedule, and announced a reduction in planned capital expenditures by more than $500 million compared to 2023. The divestiture of non-core assets, including a $223 million sale of its Sinofert stake, provided additional cash flow. Nutrien is focused on enhancing core business capabilities, optimizing its supply chain, and pursuing strategic growth opportunities through acquisitions and share repurchases.

Nutrien Financial Statement Overview

Summary
Nutrien's financial health presents a mixed performance. Stable profitability margins and a strong equity position are positives, but declining revenue and free cash flow growth are concerning. Despite strong operational cash flow generation, challenges remain in sustaining net income and revenue growth.
Income Statement
70
Positive
The company's income statement shows a mixed performance. The gross profit margin for TTM (Trailing-Twelve-Months) is 28.47%, which is decent, but the net profit margin is low at 2.05%, indicating challenges in converting revenue into profit. Revenue growth has been negative recently, declining by 8.91% from 2024 to 2025, which is concerning. EBIT and EBITDA margins for TTM are moderate at 10.51% and 18.47%, respectively. Overall, the income statement reflects stable margins but with a downward revenue trend.
Balance Sheet
75
Positive
The balance sheet presents a solid equity position with an equity ratio of 45.32% for TTM, indicating a strong equity cushion. The debt-to-equity ratio stands at 0.61, suggesting moderate leverage. Return on equity (ROE) is low at 2.19%, showing limited profitability relative to equity. Despite some leverage, the company's balance sheet is stable, with a good proportion of assets financed by equity.
Cash Flow
65
Positive
Cash flow metrics indicate some areas of concern. Free cash flow growth has declined significantly by 37.79% from 2024 to TTM. The operating cash flow to net income ratio is robust at 5.58, suggesting efficient cash generation relative to earnings. However, the free cash flow to net income ratio of 1.63 for TTM highlights potential issues in maintaining free cash flow levels. Overall, cash flow performance shows strong operational cash flow but declining free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue25.68B25.97B29.06B37.88B27.71B20.91B
Gross Profit7.31B7.53B8.47B15.42B9.41B5.24B
EBITDA4.74B4.21B4.88B12.07B6.58B2.89B
Net Income527.00M674.00M1.26B7.66B3.15B459.00M
Balance Sheet
Total Assets53.07B51.84B52.75B54.59B49.95B47.19B
Cash, Cash Equivalents and Short-Term Investments895.00M853.00M941.00M901.00M499.00M1.45B
Total Debt14.71B12.81B12.57B11.93B10.85B11.36B
Total Liabilities29.00B27.40B27.55B28.72B26.25B24.83B
Stockholders Equity24.04B24.41B25.16B25.82B23.65B22.36B
Cash Flow
Free Cash Flow859.00M1.38B2.47B5.67B2.10B1.77B
Operating Cash Flow2.94B3.54B5.07B8.11B3.89B3.32B
Investing Cash Flow-1.88B-2.13B-2.96B-2.90B-1.81B-1.20B
Financing Cash Flow-636.00M-1.45B-2.06B-4.73B-3.00B-1.34B

Nutrien Technical Analysis

Technical Analysis Sentiment
Positive
Last Price80.50
Price Trends
50DMA
79.98
Positive
100DMA
76.06
Positive
200DMA
71.04
Positive
Market Momentum
MACD
0.72
Positive
RSI
43.26
Neutral
STOCH
12.59
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NTR, the sentiment is Positive. The current price of 80.5 is below the 20-day moving average (MA) of 82.83, above the 50-day MA of 79.98, and above the 200-day MA of 71.04, indicating a neutral trend. The MACD of 0.72 indicates Positive momentum. The RSI at 43.26 is Neutral, neither overbought nor oversold. The STOCH value of 12.59 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:NTR.

Nutrien Peers Comparison

Overall Rating
UnderperformOutperform
Sector (58)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
82
Outperform
$511.96M3.6530.22%8.78%
TSNTR
71
Outperform
$39.24B55.582.15%3.84%-6.74%-36.22%
58
Neutral
HK$16.25B4.26-6.43%7.78%-3.39%-61.30%
57
Neutral
$41.57M-201.16%-91.55%-495.60%
TSNPK
45
Neutral
C$26.86M-32.62%-39.06%-9.07%
TSKRN
43
Neutral
C$8.79M-35.90%-16.48%
40
Underperform
$11.35M-32.32%-47.01%95.62%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:NTR
Nutrien
79.20
11.91
17.70%
TSE:IFOS
Itafos
2.70
1.38
104.70%
TSE:ERTH
EarthRenew
0.08
0.03
60.00%
TSE:NPK
Verde Agritech
0.52
-0.27
-34.18%
TSE:KRN
Karnalyte Resources
0.16
0.03
23.08%
TSE:MGRO
MustGrow Biologics
0.82
0.07
9.33%

Nutrien Corporate Events

Shareholder MeetingsBusiness Operations and Strategy
Nutrien Reports Strong Shareholder Support at 2025 Annual Meeting
Positive
May 8, 2025

Nutrien Ltd. announced the results of its 2025 annual meeting, where 74.48% of common shares were represented. All 12 director nominees were elected with high approval rates, KPMG LLP was re-appointed as auditor, and a non-binding advisory vote on executive compensation was approved. These outcomes reflect strong shareholder support and reinforce Nutrien’s strategic direction and governance.

DividendsBusiness Operations and Strategy
Nutrien Declares Quarterly Dividend of US$0.545 per Share
Positive
May 7, 2025

Nutrien Ltd. has declared a quarterly dividend of US$0.545 per share, payable on July 18, 2025, to shareholders of record as of June 30, 2025. This announcement reflects Nutrien’s commitment to returning value to shareholders and highlights its robust financial position, which supports its strategic investments and operations in the agricultural sector.

Business Operations and StrategyFinancial Disclosures
Nutrien Ltd. Reports First Quarter 2025 Results, Maintains Positive Outlook
Positive
May 7, 2025

Nutrien Ltd. reported its first quarter 2025 results, highlighting net earnings of $19 million and adjusted EBITDA of $0.9 billion. Despite challenges such as weather-related sales delays and increased natural gas costs, the company maintained its full-year guidance, reflecting confidence in its operational efficiency and strategic capital allocation. Nutrien’s strong potash sales and increased ammonia operating rates are expected to support a positive outlook for the year, with plans to focus on high-value investments and shareholder returns.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 17, 2025